From: TEDLOCK@Pathfinder.hsc.usc.edu
Date: Thu Jul 27 1995 - 17:47:01 EST
I was pleased to see David Hedley's response to Vince Shankey's message. I couldn't agree more. The future of clinical cytometry lies in new applications and that means transfer of basic research into clinical flow cytometry labs. Many of us are aware of the potential for clinical applications of published basic work, but there are problems in translation which include the expense of R&D, acceptance by the clinical community and and third party carriers for reimbursement, etc. As incoming President of the Clinical Cytometry Society (CCS), Editor of the CCS Newsletter (first issue just out) and co-editor-in-Chief of Communications in Clinical Cytometry, my major goal is to promote the development of new clinical applications. Therefore, I welcome anyone's comments and suggestions as to how we as clinical flow cytometrists can best achieve this. As Hedley says we have invited basic scientists to speak in Charleston every year, but the type of dialogue we want has not developed. Forum meetings will help and are planned and maybe a dialogue thru this mailing list and the CCS Newsletter and journal will help. An encouraging development is that representatives of CCS and CCD (ISAC) recently met and made progress towards consolidation of efforts in an attempt to rid ourselves of "intermindable turf wars". Hopefully this progress will continue. Please send your comments directly to me via e-mail, fax or mail. John W. Parker, M.D. USC School of Medicine Department of Pathology 2250 Alcazar St., CSC 108 Los Angeles, CA 90033-4523 PHONE: 213-342-2920 FAX: 213-342-2990 E-MAIL: tedlock@pathfinder.hsc.usc.edu
This archive was generated by hypermail 2.1.6 : Thu Jan 01 2004 - 17:30:35 EST
